Clinical Research Directory

Inclusion Criteria: * Adult males and females (aged 18 and over) * Confirmed by cytology or histology incurable PDAC who are planned to receive medical care for cancer in the first-line setting at the enrolling institution within ≤ 2 weeks * Written informed consent before any study procedures * Performance status: ECOG 0-2 * Ability to read and respond to questions or able to complete questions with minimal assistance required from an interpreter or family member * Planning to receive all medical care for cancer at the enrolling institution. Exclusion Criteria: * Patients who are already receiving care from the palliative care service are not eligible for participation in the study * Exhibiting signs of overt psychopathology or cognitive dysfunction * Any medical condition that the Investigator considers significant to compromise the safety of the patient or that impairs the interpretation of study assessments * Patient participating in another interventional study during the surveillance period. This is only relevant for studies that might interfere with the intervention. Participation in protocols related only to treatment will not preclude participation in the present study. Cases of doubt will be settled by the protocol responsible.